[go: up one dir, main page]

BR9911020A - Novas composições farmacêuticas para tratamento e salvamento, e método para a sua preparação - Google Patents

Novas composições farmacêuticas para tratamento e salvamento, e método para a sua preparação

Info

Publication number
BR9911020A
BR9911020A BR9911020-2A BR9911020A BR9911020A BR 9911020 A BR9911020 A BR 9911020A BR 9911020 A BR9911020 A BR 9911020A BR 9911020 A BR9911020 A BR 9911020A
Authority
BR
Brazil
Prior art keywords
preparation
chloride
volume
weight
rescue
Prior art date
Application number
BR9911020-2A
Other languages
English (en)
Inventor
Chaoying Zhao
Original Assignee
Chaoying Zhao
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chaoying Zhao filed Critical Chaoying Zhao
Publication of BR9911020A publication Critical patent/BR9911020A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)

Abstract

"NOVAS COMPOSIçõES FARMACêUTICAS PARA TRATAMENTO E SALVAMENTO, E MéTODO PARA A SUA PREPARAçãO". A presente invenção refere-se a uma composição farmacêutica e o método para o seu preparo. A composição compreende 1,5-6,9% (peso/volume) de uma ou mais substâncias selecionadas de cloreto de sódio, bicarbonato de sódio, cloreto de potássio, sulfato de magnésio, cloreto de cálcio, gluconato de cálcio e outros do gênero, e 3~18% (peso/volume) de uma ou mais substâncias selecionadas de hidróxi etil amido, dextran, carboximetilamido, polivinil-pirrolidona, derivados de gelatina, e outros do gênero bem como o restante de injeções convencionais, contanto que o cloreto de sódio não seja menos que 1,5% (peso/volume). A composição farmacêutica da presente invenção é usada para tratar e salvar o ferido e pacientes, bem como tratar choque, suas vantagens incluem uso económico e conveniente, efeito curativo rápido e satisfatório, manutenção de tempo longo, usos extensivos e outros.
BR9911020-2A 1998-05-15 1999-04-16 Novas composições farmacêuticas para tratamento e salvamento, e método para a sua preparação BR9911020A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN98108902A CN1068778C (zh) 1998-05-15 1998-05-15 救治用的药物组合物及其制备方法
PCT/CN1999/000055 WO1999059602A1 (en) 1998-05-15 1999-04-16 Novel pharmaceutical composition for use in emergency treatment and preparation method thereof

Publications (1)

Publication Number Publication Date
BR9911020A true BR9911020A (pt) 2002-03-05

Family

ID=5219795

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9911020-2A BR9911020A (pt) 1998-05-15 1999-04-16 Novas composições farmacêuticas para tratamento e salvamento, e método para a sua preparação

Country Status (20)

Country Link
US (2) US6986905B1 (pt)
EP (1) EP1078636B1 (pt)
JP (1) JP2002515441A (pt)
KR (1) KR20010043585A (pt)
CN (1) CN1068778C (pt)
AP (1) AP1185A (pt)
AT (1) ATE456954T1 (pt)
AU (1) AU754537B2 (pt)
BR (1) BR9911020A (pt)
CA (1) CA2332038C (pt)
DE (1) DE69941996D1 (pt)
EA (1) EA003369B1 (pt)
IL (1) IL139658A (pt)
MX (1) MXPA00011216A (pt)
OA (1) OA11553A (pt)
PL (1) PL196087B1 (pt)
RO (1) RO122394B1 (pt)
TR (1) TR200003315T2 (pt)
UA (1) UA72735C2 (pt)
WO (1) WO1999059602A1 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9904471A (pt) * 1999-08-02 2001-03-13 Mateus Sommer Neto Composção coloidal para correção estética
EP1398324A1 (en) * 2002-09-11 2004-03-17 Fuji Photo Film B.V. Use of recombinant gelatin-like proteins as plasma expanders and compositions suitable for plasma substitution
BRPI0409867A (pt) * 2003-05-01 2006-05-16 Innogene Kalbiotech Pte Ltd composição farmacêutica contendo lactato e usos da mesma
US20060018852A1 (en) 2003-08-22 2006-01-26 L'oreal Compositions containing topical active agents and pentylene glycol
US7906125B2 (en) 2003-09-18 2011-03-15 Boston Scientific Scimed, Inc. Solid or semi-solid therapeutic formulations
US20050064045A1 (en) * 2003-09-18 2005-03-24 Sheng-Ping Zhong Injectable therapeutic formulations
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
US8263109B2 (en) 2005-05-09 2012-09-11 Boston Scientific Scimed, Inc. Injectable bulking compositions
CN100333728C (zh) * 2005-05-11 2007-08-29 中国人民解放军第二军医大学 一种复方电解质果糖注射液
CN100394924C (zh) * 2005-09-23 2008-06-18 赵超英 一种高渗液药物组合物在制备麻醉前使用的药物中的应用
CN101209344B (zh) * 2006-12-28 2012-07-04 赵超英 高渗液组合物在制备促进伤口愈合的药物中的应用
US8790714B2 (en) * 2007-08-03 2014-07-29 Nucitec, S.A. De C.V. Compositions and methods for treatment and prevention of osteoarthritis
DE102007047040A1 (de) * 2007-10-01 2009-04-16 Fresenius Kabi Deutschland Gmbh Transparentes Kältegel
CN100544734C (zh) * 2007-10-16 2009-09-30 中国大冢制药有限公司 复方果糖电解质注射液及其制备方法
CN101167740B (zh) * 2007-10-16 2010-05-19 中国大冢制药有限公司 复方醋酸钠电解质注射液及其制备方法
MD4117C1 (ro) * 2010-07-30 2012-02-29 Институт Химии Академии Наук Молдовы Pudră cu capacitate hemostatică şi regenerativă (variante) şi procedeu de obţinere a acesteia
CN102000109B (zh) * 2010-09-30 2013-06-05 泰山医学院 基于氢为治疗物质的药物制剂及其制备方法
RU2471489C1 (ru) * 2011-12-22 2013-01-10 Учреждение Российской академии медицинских наук Научно-исследовательский институт фармакологии Сибирского отделения РАМН (НИИ фармакологии СО РАМН) Средства, повышающие выживаемость при травматическом шоке
CN103845358B (zh) * 2012-12-04 2015-11-25 江苏恒瑞医药股份有限公司 包含羟乙基淀粉和含有碳酸氢根离子的电解质溶液的药物组合物
CN105431145B (zh) 2013-04-05 2019-12-10 Sc医药品有限公司 用于呋塞米的皮下施用的药物制剂
CN104644669A (zh) * 2013-11-19 2015-05-27 北大方正集团有限公司 一种急救用的代血浆药物组合物及其制备方法
CA3251941A1 (en) 2018-01-12 2025-02-24 Metimedi Pharmaceuticals Co., Ltd. Methods of treating chronic inflammatory diseases
WO2020120482A1 (en) 2018-12-10 2020-06-18 Sq Innovation Ag Pharmaceutical compositions of furosemide and uses thereof
EP3906020B1 (en) 2019-01-04 2025-12-31 SQ Innovation AG Pharmaceutical compositions of torsemide and their uses
CN113271923B (zh) 2019-01-04 2025-05-13 Sq创新股份公司 呋塞米的药物组合物及其用途
CA3128033A1 (en) 2019-01-31 2020-08-06 Scpharmaceuticals Inc. Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same
US12419850B1 (en) 2024-03-21 2025-09-23 GanD, Inc. Bioactive fluid compositions
CN119868405A (zh) * 2024-12-31 2025-04-25 上海怿勤生物科技有限公司 一种基于果糖的复方电解质注射液及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5835485B2 (ja) * 1976-02-03 1983-08-03 株式会社ミドリ十字 酸素運搬輸液
US4908350A (en) * 1985-10-31 1990-03-13 The Regents Of The University Of California Hyperosmotic/hyperoncotic solutions for resuscitation of hypodynamic shock
US4927806A (en) * 1987-04-23 1990-05-22 The Regents Of The University Of California Saturated salt/concentrated dextran formulation to treat hemorrhage
CN1042474A (zh) * 1988-11-10 1990-05-30 济南军区药物研究中心 果胶代血浆及制备方法
US5292535A (en) * 1990-06-15 1994-03-08 Regents Of The University Of California Hyperosmotic solutions for isonatremic resuscitation
JPH0469341A (ja) * 1990-07-05 1992-03-04 Otsuka Pharmaceut Factory Inc Ｔｐｎ用糖電解質液
US5704297A (en) * 1991-02-06 1998-01-06 The Dupont Merck Pharmaceutical Company Dry powder composition of hydroxyethyl starch suitable for reconstitution
US5248507A (en) * 1991-05-31 1993-09-28 Board Of Regents, The University Of Texas System Hypertonic isochloremic formulation for circulatory shock
JPH06135852A (ja) * 1992-10-23 1994-05-17 Takada Seiyaku Kk ウリナスタチン注射液
CN1102851C (zh) * 1993-06-04 2003-03-12 生物时间公司 类血浆溶液
RU2056837C1 (ru) * 1995-03-22 1996-03-27 Государственный институт кровезаменителей и медицинских препаратов Лекарственное средство "квинтасоль" для нормализации нарушений кислотно-щелочного равновесия и водно-электролитного баланса
GB9526741D0 (en) * 1995-12-30 1996-02-28 Sobering Thoughts Ltd Product for combatting dehydration
WO1998008500A1 (en) * 1996-08-26 1998-03-05 Board Of Regents, The University Of Texas System Hypertonic arginine compositions and methods
CN1156587A (zh) * 1996-12-13 1997-08-13 孙旭光 无晶甘露醇注射液及其制备方法
CN1195527A (zh) * 1997-04-07 1998-10-14 毕研文 低盐中分子羟乙基淀粉液

Also Published As

Publication number Publication date
AP2000002010A0 (en) 2000-12-31
DE69941996D1 (de) 2010-03-25
US20050288235A1 (en) 2005-12-29
KR20010043585A (ko) 2001-05-25
EA003369B1 (ru) 2003-04-24
CA2332038A1 (en) 1999-11-25
PL196087B1 (pl) 2007-12-31
UA72735C2 (en) 2005-04-15
OA11553A (en) 2004-05-26
PL344246A1 (en) 2001-10-22
JP2002515441A (ja) 2002-05-28
AU3514799A (en) 1999-12-06
EP1078636A4 (en) 2003-07-02
US7309502B2 (en) 2007-12-18
IL139658A (en) 2005-12-18
AP1185A (en) 2003-07-04
EP1078636A1 (en) 2001-02-28
WO1999059602A1 (en) 1999-11-25
MXPA00011216A (es) 2003-04-22
HK1035146A1 (en) 2001-11-16
EA200001191A1 (ru) 2001-08-27
CN1068778C (zh) 2001-07-25
ATE456954T1 (de) 2010-02-15
CA2332038C (en) 2009-01-27
CN1235833A (zh) 1999-11-24
IL139658A0 (en) 2002-02-10
EP1078636B1 (en) 2010-02-03
US6986905B1 (en) 2006-01-17
RO122394B1 (ro) 2009-05-29
TR200003315T2 (tr) 2001-06-21
AU754537B2 (en) 2002-11-21

Similar Documents

Publication Publication Date Title
BR9911020A (pt) Novas composições farmacêuticas para tratamento e salvamento, e método para a sua preparação
BR9807675A (pt) Processos para fabricação de um complexo argimina-silicato-inositol, para prevenir ou inibir a arterioesclerose em um indivìduo, para suplementação dietética de arginina, para prevenção da desmineralização de ossos ou degradação de cartilagens em um indivìduo com necessidade do mesmo, para tratamento de um mamìfero para aliviar os efeitos patológicos da osteoporose, osteogenesis imperfecta, fraturas ósseas, osteoartrites e outras doenças de ossos e cartilagens, complexo arginina-silicato-inositol, uso do mesmo, e formulação farmacêutica opositora da desmineralização óssea e inibidora da degradação de cartilagem
BR0111381A (pt) Composições, kits e métodos para promover benefìcios definidos a saúde
BR9714117A (pt) Processo para preparar condimentos de alimento, ingrediente de alimento e composições de item de alimento, condimento e seu uso
BR9810547A (pt) Absorção de minerais pelas células intestinais
BR9712449A (pt) Composições para redução dos odores e umidade em excesso dos corpos
BG102689A (bg) Фармацевтичен аерозолен състав за използване при лечение на респираторни смущения
BR9815442A (pt) Liberação terapêutica dirigida de compostos de vitamina d
BR0316364A (pt) Combinação de terapia do câncer com um composto anticâncer ativado com gst e uma outra terapia anticâncer
UY24308A1 (es) Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol, para administracion oral
BR9611815A (pt) Tablete de mascar com ação efervescente
BRPI0515411A (pt) composição de mano-oligossacarìdeo, composição alimentìcia, e, método para a redução das relações de gordura corporal ou gordura abdominal em um ser humano
BR0306306A (pt) Composição contendo extrato de matricária e uso desta
BR0215904A (pt) Métodos e composições para prover glutamina
MX9501849A (es) Nuevos compuestos biciclicos-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos.
Wapnir et al. Gum arabic promotes rat jejunal sodium and water absorption from oral rehydration solutions in two models of diarrhea
JP2001527022A5 (pt)
BR0309595A (pt) Injeção produzida a partir de ixeris sonchifolia hance para o tratamento de doenças vasculares cardiocerebrais e doenças de fundo, e método para a produção da mesma
BRPI0409413A (pt) composição farmacêutica, uso de um ácido ou sal biliar não conjugado, e, métodos para intensificar a absorção de um princìpio macromolecular ativo em um pacinete e para tratar um paciente que esteja sofrendo de uma condição ou doença tratável
US4185108A (en) Antiosteoporotic agents
BR9708297A (pt) Compostos composição farmacéutica cosmposição e uso de uma composição cosmética
BR9914834A (pt) Agente de tratamento de patobolismo ósseo, e, método para intensificar a atividade de fator inibidor de osteoclastogênese
BR9811843A (pt) Sistema de agente de consevação para produtos de tratamento corporal
US4125621A (en) Antiosteoporotic agents
BR0212249A (pt) Composto, composição farmacêutica, método de tratamento ou profilaxia de doenças, e, uso de um composto

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: A61K 31/718, A61K 31/721, A61K 31/715, A61K 31/732, A61K 31/734, A61K 31/7016,A61K 31/7004, A61K 31/047, A61K 31/164, A61K 33/14, A61K 9/08, A61P 7/08

Ipc: A61K 31/715 (2009.01), A61K 9/08 (2009.01)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 12A E 13A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.